In glucocorticoid-dependent polymyalgia rheumatica, tocilizumab improved a composite clinical outcome at 24 wk

Authors: David S. Pisetsky

Published: 2023-01-02

DOI: 10.7326/j22-0107

Source: Full article

Abstract

No abstract found.